Companies / BOC Sciences / Sarilumab
BOC Sciences

Sarilumab | BOC Sciences

(0) Write Review

Sarilumab is a monoclonal antibody used in the treatment of autoimmune diseases, specifically rheumatoid arthritis. Sarilumab targets and inhibits the interleukin-6 receptor (IL-6R), which is involved in the inflammatory pathway that contributes to autoimmune diseases like rheumatoid arthritis. By blocking IL-6R, sarilumab helps to reduce inflammation and alleviate symptoms associated with rheumatoid arthritis. It is indicated for the treatment of moderate to severe rheumatoid arthritis in adult patients who have not responded adequately to conventional disease-modifying antirheumatic drugs (DMARDs) such as methotrexate. Sarilumab is often used in combination with methotrexate or as monotherapy.

Reviews

(0) | Be the first to review this product
No reviews yet

ABOUT THE COMPANY

BOC Sciences
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
Scientific Products
  • See More
    • Upcoming Virtual Events
    Upcoming Webinars